Latest Strategic Capital Raising News

Hydralyte North America reported a 16% rise in Q1 FY25 net sales and improved gross margins, supported by a strategic capital raise and upcoming product launches targeting brain and gut health.

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

QMines Limited reports a 42% increase in Indicated resources at Develin Creek following maiden drilling, completes a $4 million capital raise, and moves to acquire the Mount Mackenzie gold-silver project, signaling a strategic expansion in Queensland.

Cosmos Exploration has progressed its lithium brine extraction testing in Bolivia using Vulcan Energy’s VULSORB® technology and reported promising uranium mineralogy results from its Canadian projects, supported by a $1.25 million capital raise.

BauMart Holdings Limited has announced a rights issue to raise approximately $482,000 by offering new shares at a steep discount, aiming to accelerate equipment delivery, fund R&D, and support international recruitment.

Western Gold Resources has made significant strides in advancing its Gold Duke Project, securing a preferred mining contractor with a deferred payment facility and raising over $1.7 million in capital to support development towards production.

Terrain Minerals reports robust March quarter progress with standout gold and silver drilling results at Smokebush, alongside advancing gallium and rare earth projects and a strategic capital raise.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

Koonenberry Gold Limited has raised $2 million through a strategic placement to accelerate exploration at its Enmore and Lachlan projects, including an expanded drilling program at Sunnyside.

Micro-X Limited has initiated a $2.7 million retail entitlement offer as part of a broader $6 million capital raising, supporting its strategic pivot towards medical imaging technologies and strengthening its balance sheet.

Osteopore Limited has announced a $20 million convertible notes offering aimed at bolstering its capital for ongoing operations and future projects. The highly speculative offer targets sophisticated investors and underscores the company’s strategic funding approach amid competitive medical device markets.

Amaero has completed a A$22 million institutional placement, concluding nearly A$100 million raised since 2022 and positioning itself for commercialisation in FY2026 with a robust balance sheet.